During the past decade, Wakayama Medical University Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 13 clinical trials were completed, i.e. on average, 21% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 12 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wakayama Medical University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Amgen" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Takeda" with 5 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wakayama Medical University Hospital" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Human Genome Center, Institute of Medical Science, University of Tokyo" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Wakayama Medical University Hospital" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "Wakayama Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Wakayama Medical University Hospital" are "Drug" (59 trials), "Biological" (5 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Carboplatin" (10 trials), "Pemetrexed" (8 trials), "Atezolizumab" (6 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Wakayama Medical University Hospital" are 68 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wakayama Medical University Hospital". undefined are not yet recruiting, 18 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in Wakayama Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wakayama Medical University Hospital, 10 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".